Introduction
For the detection and staging of cancer, different imaging techniques are available. Some of the widely used imaging modalities are magnetic resonance imaging (MRI), X-Ray computed tomography (CT), X-Ray, ultrasound (US), positron emission tomography (PET), fluorescence imaging, etc 1, 2, 3, 4 . But, some of the existing imaging techniques are either invasive, have harmful radiation, or are slow, expensive, bulky, or unfriendly to patients. Thus, there is a constant need to develop new, fast, and cost-effective imaging techniques for diagnostics and therapy 5 .
Photoacoustic imaging (PAI) is an emerging imaging technique, which combines rich optical contrast with high ultrasonic resolution at a deeper imaging depth 5, 6, 7, 8, 9 . In PAI, a short laser pulse is used for tissue irradiation. The light gets absorbed by the tissue which leads to a small temperature rise. Due to thermoelastic expansion, pressure waves (in the form of acoustic waves) are generated within the tissue. The generated acoustic waves (also known as photoacoustic (PA) waves) are acquired with a wideband ultrasound transducer (UST) outside the tissue boundary. These acquired PA signals can be used to reconstruct PA images, revealing the structural and functional information inside the tissue. PAI has a wide array of applications, including: blood vessel imaging, sentinel lymph node imaging, brain vasculature imaging, tumor imaging, molecular imaging, etc. 10, 11, 12, 13, 14, 15 PAI has numerous applications because of its advantages, namely: deeper penetration depth, good spatial resolution, and high soft tissue contrast. The contrast in PAI can be endogenous from blood, melanin, etc. When the endogenous contrast is not strong enough, exogenous contrast agents like organic dyes, nanoparticles, quantum dots, etc. 16, 17, 18, 19, 20, 21 can be used for improving the contrast.
Although PAI has numerous benefits relative to other imaging techniques, clinical translation is still a very big challenge. The main limitations are the bulky nature of the lasers being used, most of the USTs used for data acquisition are not compatible with clinical US systems, and the non-availability of commercially available clinical US imaging systems which give access to raw channel data. Only recently, commercial clinical US machines with access to raw data have become available 22 . In this work, we aim to demonstrate the feasibility of PAI with a handheld setup using a clinical US platform. We aim to demonstrate this by showing non-invasive imaging of sentinel lymph nodes (SLNs) in a small animal model.
Invasive breast tumors are one of the leading causes of cancer death among women. Diagnosing and staging breast cancer early is vital for deciding treatment strategies, which play an important role in the prognosis of the patient. For breast cancer staging sentinel lymph node biopsies (SLNB) are usually used 23, 24 . SLN is the primary lymph node where the possibility of finding cancer cells is the highest due to metastasis. SLNBs involve injecting a dye or a radioactive tracer, followed by cutting open the area with a small incision, and then locating the SLN visually in case of dyes or with the help of a Geiger counter, in case of a radioactive tracer. After identification, a few SLN are removed for histopathological studies 24, 25 1. Handheld Real-Time Clinical PA and US Imaging System 1. The schematic of the handheld clinical PAI system 33 is shown in Figure 1a . It consists of a optical parametric oscillator (OPO) laser pumped by a frequency doubled nanosecond pulsed Nd:YAG pump laser, a bifurcated optical fiber bundle (Figure 1b) , a custom-made 3D printed handheld probe holder (Figure 1c ) 33 , clinical dual modal US and PA system, and a clinically compatible linear array UST (see Table of  Materials) . 2. Run the software provided by the manufacturer in the clinical US system by clicking on the icon for the software from the desktop. 3 . From the touch screen, select the 'research' button to operate the US system in the research mode. Click on the combined US and PA imaging script from the list of scripts and click the run button for imaging in the combined mode. 4. Synchronize the clinical US system with the laser using the laser trigger out or using a photodiode.
NOTE: Connect the fixed sync out from the laser to the US system sync in. Make sure to provide positive Transistor-transistor logic (TTL) signal as the sync signal. A photodiode signal can also be used for sync purpose. The US system sync in is connected to the photodiode detector using a photodiode bias module. Whenever the laser is ON, the photodiode gives a signal to trigger and sync both the laser and the US system. Perform this step every time. 5. To turn on the laser, switch on AC power, and turn the key to the left on the laser controller. Start the laser after ensuring the repetition rate is 10 Hz (F10 will be displayed on the display) and the Q-switch delay is as low as 170 µs to ensure low laser energy. To set the delay, press the select key till you see the delay value and increase it to 170. NOTE: The laser takes approximately 20 min to warm up. 6. Open the software interface on a computer and in the goto menu enter the wavelength as 675 nm and press the 'start' button to set the wavelength at 675 nm. NOTE: The laser can be tuned from 670 to 2,500 nm, however, it is unstable at 670 nm. 7. Press the shutter button and turn the laser on using the switch to align the laser beam to the fiber input. 8. Using a 1 inch (2.5 cm) diameter plano-convex lens of focal length 15 mm, focus the laser beam to the fiber bundle such that all the light falls on the fiber input end. NOTE: The optical fiber has 1,600 small fibers bundled together. It is bifurcated in the middle with two rectangular output ends which have 800 optical fibers each. The 800 fibers are packed into an area of 0.1 x 4 cm, to match with the dimensions of the UST. The core diameter of each optical fiber is 185 µm, with a numerical aperture of 0.22. 9. Switch OFF the laser after alignment. 10. From the 4 probe holders with different angles of illumination (0°, 5°, 10°, and 15°) choose the appropriate probe holder based on the application (depth of imaging, size of the object, shape of the object, and location of the object). NOTE: The probe holders were designed and 3D printed in the lab. It has three slots, two for the bifurcated optical fibers and the central one for the UST. The dimension of the probe holder was based on the dimensions of the optical fiber and the UST. Monte Carlo simulations were done to study the light illumination required for imaging SLNs at higher depth. SNR was higher at lower depths for an illumination of 15°3 3 . 11. Fit the bifurcated optical fiber into the 3D printed probe holder at a light illumination angle of 15˚. 12. Insert the UST into the center slot of the holder. NOTE: Figure 1d shows the photograph of the probe holder with the optical fiber and UST. The linear array UST has 128 array elements. The center frequency of the UST is 8.5 MHz and the fractional bandwidth is 95%. The length of the UST is 3.85 cm. However, the system has only 64 parallel data-acquisition hardware and requires two laser pulses to collect data from all the 128 elements. Therefore, the effective frame rate of the system is half the pulse repetition rate of the laser, which is 5 frames per second 34 . 13. Adjust the distance between the UST and the fiber end to 1 cm by loosening the screws on the side and tighten it after adjusting the exact distance. NOTE: The parameters are optimized for SLN imaging with simulation and phantom experiments 33 . The UST can be secured with the two screws on the probe holder. This gives the flexibility to vary the distance between the optical fiber and the UST. 14. Switch ON the laser and make sure to obtain a rectangular laser beam spot in front of the UST. 15. Switch OFF the laser. Increase the laser energy (by increasing the delay) to the desired value for the imaging purpose.
NOTE: Refer to the manual for the maximum delay that can be set for the Nd:YAG laser. The desired delay value for this system for SLN imaging was set to 210.
. NOTE: To determine the axial and lateral resolution, find the point-spread function from the normalized PA signals along the respective directions and fit them to a Gaussian distribution function 17 . Obtain the full width at half maximum.To obtain the point spread function, it is required to image a point. However, there is another way of obtaining a point spread function when imaging a point target is difficult (as in our case, for a very tiny point target the signal is quite small and therefore we use a slightly larger target). If the target is large, instead of directly getting the point spread function, one can obtain an edge spread function. Then by taking the first derivative of the edge spread function, one can get the point spread function. Therefore, it is not absolutely necessary to use a point target to calculate the resolution 22 .
Animal Preparation for SLN Imaging
NOTE: The handheld clinical imaging system described above was demonstrated for imaging small animal SLN. For experiments, 6-to 8-weekold healthy, female rats (NTac:Sprague Dawley, 220 ± 30 g) were procured. Female rats are used because the occurrence of breast cancer in male rats is less frequent. However, male rats can also be used for the studies. Additionally, in the literature, female rats are used more widely for the SLN imaging.
1. Rat anesthetization 1. Before imaging, anesthetize the rat with the anesthesia solution, which contains a cocktail of ketamine (100 mg/mL), xylazine (20 mg/mL), and injectable saline at a proportion of 2:1:1. Add 0.2 mL of the cocktail per 100 g of animal weight to a sterile surgical 1 mL syringe with needle (27G, ½ inch). 2. Scruff the neck of the rat by hand and disinfect the right-lower quadrant of the abdomen with an alcohol swab. Inject anesthesia solution into the animal body. 3. Ensure that the animal is anaesthetized by checking for reflex on toe pinch.
2. For SLN imaging, remove hair from the region of interest gently with commercially available hair removal cream. Use as much as required to cover the area completely. Remove the cream with a wet cotton swab after 3 -5 min of application. To prevent eyes from dryness and accidental laser damage, apply artificial tear ointment. 3. Place blue underpad on the table and position the animal sideways on it. Administer inhalation anesthesia through a nose cone (0.75% of isoflurane along with oxygen (1.2 L/min)) to maintain the animal under anesthesia during experiments. Clip the pulse oximeter to the hind paw of the rat to monitor the heart rate and peripheral oxygen saturation throughout experiments. NOTE: Make sure the animal is warm using a heating pad approved for animal use.
In Vivo SLN Imaging of Rats
1. Before imaging, apply 0.5 to 1 mL of US gel on the skin using a syringe and spread it well using an applicator. Place a 0.5 cm thick chicken breast tissue slice of size 6 cm x 6 cm on the imaging area and apply more US gel on the chicken tissue to improve coupling. NOTE: LNs are located under the skin (within 2-3 mm) in rats. In humans, LNs are at a depth of 1 cm. Hence, chicken tissue is placed in the imaging area of rat to mimic the human imaging scenario. Alternatively, tissue mimicking phantoms can be used in place of chicken tissue. 2. Switch on the laser. Place the handheld probe holder on top of the chicken tissue and scan it (move the holder right to left) in the combined US and PA mode. NOTE: The area of the laser beam is approximately 3 cm 2 and fluence is calculated to be approximately 8 mJ/cm 2 , which is less than the American National Standards Institute (ANSI) safety limit (20 mJ/cm 2 ) 35 . The imaging depth is set to 2 cm in the clinical US system. Safety goggles should be worn at all times when the laser is switched on. 3. Set the imaging depth to 2 cm for PA imaging. 4. Obtain a control image of the region of interest, above the front leg in the thoracic area, by moving the handheld probe from side to side before injection of the contrast agent. NOTE: All the data is saved in the beam-formed data type for further processing. 5. Inject 0.2 mL of the contrast agent, (i.e., MB (10 mg/mL)) in the forepaw of the animal and massage it well for 2 min to facilitate contrast agent movement to the lymph nodes through the lymph vessels. 6. Scan after 5 min with the handheld probe along the chicken tissue to locate the SLN with the help of the PA signal.
NOTE: All the frames are saved in the beam-formed data type. 7. Click on the 'freeze' button from the controls on the US system and click the 'export selected frames' button from the touch screen monitor to export the recorded data. NOTE: Data can be stored in different formats namely, beam formed, scan converted, channel, and I.Q. 8. Add 2 more layers of 0.5 cm thick chicken tissue slices on top of the animal one by one and locate the SLN to demonstrate the feasibility of depth imaging up to 1.5 cm. 9. After imaging, remove all the chicken tissue slices 10. Switch off the laser. To characterize the axial and lateral resolution of the imaging system, a needle of 0.6 mm diameter was used. The PA signal along the axial and lateral direction was plotted and fitted to a Gaussian distribution function. The full width at half maximum was calculated at various depths of 1 cm, 1.5 cm, 2 cm, 2.5 cm, and 3 cm. The plot for axial resolution is shown in Figure 1e . The axial resolution was calculated to be 207 ± 45 µm. The lateral resolution is limited by the element pitch of the UST. Theoretically, the lateral resolution is 300 µm, which is the element size of the UST. The lateral resolution calculated from the acquired PA image of the needle was 351 µm.
Representative Results
MB is a Food and Drug Administration (FDA) approved dye for SLN imaging and is widely used clinically for SLNB. Therefore, MB has been used for noninvasive imaging of SLN with PAI extensively. An optimum wavelength of 675 nm was determined based on the optical spectrum and limitations of the laser tunability 36 . Figure 2a shows the photograph of the shaved region of the rat for SLN imaging. The red dashed line shows the approximate imaging plane for combined US and PA imaging. All the combined PA and US images shown are screenshots taken from the clinical US system monitor. Figure 2b shows the combined US and PA image before injection of MB. It can be noted that there is no PA signal in the image. From the US, images of the lymph nodes can be identified, but only by a trained eye as the contrast is very poor. Additionally, with plain US images, the SLN cannot be differentiated from the other lymph nodes. Figure 2c shows the combined US and PA image after MB injection. From this image, the SLN can be very easily identified due to the strong PA signal from MB in the SLN. Real-time PA spectroscopy can be done with the clinical PA imaging system by varying the wavelength of the laser while imaging. MB has a sharp absorption peak around 670 nm. So, by varying the wavelength from 670 nm to 800 nm, the PA signal from the SLN will disappear slowly. SLNs are usually located between 1-2 cm of depth from the skin surface in humans. In small animals, SLN can be found just beneath the skin. Therefore, to mimic a human SLN imaging scenario, chicken breast tissue was placed on the top of the skin surface of the rat. Additionally, to demonstrate depth imaging, the thickness of chicken breast tissue is increased in steps of 0.5 cm up to 1.5 cm. Up to 1.5 cm deep imaging has been observed with the current setup. The imaging depth could be further improved with higher laser energy. Non-invasive identification, together with FNAB of SLN, will reduce complications associated with SLNB surgery. Ultrasonography is the most commonly used technique for needle guidance until now 37 . But, the contrast of US is very poor to visualize needle guidance in tissue. Noninvasive, real-time needle guidance for biopsy of SLN with PAI is shown here. Figure 4a shows the image of needle guidance by US imaging only into the SLN. It is evident that the contrast provided by US is not good and needs a trained eye to track and guide the needle properly. Figure 4b shows the combined US and PA image of the needle guidance in vivo. With PA imaging, the contrast obtained from the needle is very high and can be easily monitored and tracked in vivo. Movie S1 shows the video of PA imaging for in vivo needle tracking. Once the needle reaches the SLN, a small portion of the SLN tissue can be taken out for further histological examination.
Movie S1: Please click here to download this file.
Discussion
Currently the cost of screening, diagnosis, and treatment of cancer is very high. There are different imaging modalities which are being used for cancer screening and diagnosis. However, a lot of these imaging techniques have limitations including bulky machine size, invasive diagnosis, unfriendliness to patients, too expensive, requirement of ionizing radiation, or use of radioactive contrast agents. Therefore, an efficient, cost effective, real-time imaging and guiding system is much needed. Combined US and PA imaging is a technique that can be used for effective, non-invasive screening, diagnosis, and staging of cancer. Clinical PA imaging can be made more feasible with FDA approved contrast agents such as MB. As PA imaging is a non-invasive procedure, it eliminates the complications related to SLNB surgery.
There are some challenges that need attention before clinical PAI becomes successful. Firstly, the size of the laser used for PAI has to be made more compact. They are large, heavy, and often require an optical table to house them. They are also sensitive to very small changes in alignment, hence not portable for clinical use. Small diode lasers yield very low power compared to bulky OPO lasers and are often not tunable. Recently, portable OPO lasers have been made available. This can greatly solve the problem of portability. Secondly, the integration of light delivery with the US probe with high light coupling efficiency is a challenging task. Small diode lasers have been integrated within the UST itself. However, the power is much lower and requires custom made modifications in the USTs which makes it even more expensive 38 . Effective external coupling of light and UST needs to be done. Thirdly, the availability of a commercial clinical US imaging system for PAI with access to raw channel data and compatible USTs for data acquisition. Recently, such systems have become available commercially.
Other minor challenges are to increase the effective imaging frame rate. This is currently limited by the pulse repetition rate of the laser. Most OPO lasers have a pulse repetition rate of up to 200 Hz. Pulsed diode lasers have a much higher pulse repetition rate of a few kHz. The use of these lasers will help in improving the imaging frame rate significantly 34 . Also, the availability of very few FDA approved contrast agents (like MB) is another limitation for clinical PAI. A lot of research is being carried out in finding and testing different contrast agents for PAI. Other minor aspects also need to be taken into consideration while performing handheld PA imaging. As we are using a handheld probe on the animal, there will be some error due to motion of the hands while handling the holder. Utmost care should be taken to minimize this error. Also, while showing real-time needle tracking, positioning the needle exactly in-plane to the center of the UST is very crucial to obtain the maximum PA signal from the needle and track it successfully. By overcoming all these challenges, PAI can be a viable clinical imaging tool for widespread applications (cell organelles to organs) including imaging of blood vessels, brain vasculature, tumors, SLN, urinary bladder, and circulating tumor cells.
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